Anna Maria Spera

423 total citations
20 papers, 224 citations indexed

About

Anna Maria Spera is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Anna Maria Spera has authored 20 papers receiving a total of 224 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Epidemiology and 6 papers in Hepatology. Recurrent topics in Anna Maria Spera's work include Hepatitis C virus research (5 papers), COVID-19 Clinical Research Studies (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Anna Maria Spera is often cited by papers focused on Hepatitis C virus research (5 papers), COVID-19 Clinical Research Studies (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Anna Maria Spera collaborates with scholars based in Italy, United States and Singapore. Anna Maria Spera's co-authors include Grazia Tosone, Pasquale Pagliano, R. Orlando, Silvano Esposito, Tiziana Ascione, Anna Maria Bianchi, Salvatore Smirne, A. Oldani, S. Cerutti and Marco Zucconi and has published in prestigious journals such as Journal of Neurology, Journal of Pain and Journal of Pediatric Gastroenterology and Nutrition.

In The Last Decade

Anna Maria Spera

17 papers receiving 217 citations

Peers

Anna Maria Spera

EPIDE

HEPAT

ECP

G E Erhabor Nigeria

Eileen Eriksen United States

J. Marquie-Beck United States

Daniel Gruener United States

Luis Eduardo Veras PINTO Brazil

Ali Mofredj France

A Beyer United States

M. C. Silveri Italy

Federica Sozio Italy

Mats Ingmar Fortmann Germany

G E Erhabor Nigeria

Anna Maria Spera

96 ×1.0

EPIDE

59 ×0.9

HEPAT

82 ×1.2

11 ×0.3

25 ×1.1

ECP

Citations per year, relative to Anna Maria Spera Anna Maria Spera (= 1×) peers G E Erhabor

Countries citing papers authored by Anna Maria Spera

Since Specialization

Citations

This map shows the geographic impact of Anna Maria Spera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Maria Spera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Maria Spera more than expected).

Fields of papers citing papers by Anna Maria Spera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Maria Spera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Maria Spera. The network helps show where Anna Maria Spera may publish in the future.

Co-authorship network of co-authors of Anna Maria Spera

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Maria Spera. A scholar is included among the top collaborators of Anna Maria Spera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Maria Spera. Anna Maria Spera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spera, Anna Maria, Tiziana Ascione, Mónica Chan, et al.. (2025). Fracture-Related Infections: Current Status and Perspectives from the International Society of Antimicrobial Chemotherapy. Antibiotics. 14(11). 1095–1095.

Pagliano, Pasquale, Francesco Antonio Salzano, Anna Maria Spera, et al.. (2025). How do drug discovery scientists address the unmet need of long COVID syndrome therapeutics and what more can be done?. Expert Opinion on Drug Discovery. 20(10). 1251–1265.

Pagliano, Pasquale, Anna Maria Spera, Carmine Sellitto, et al.. (2023). Preclinical discovery and development of nirmatrelvir/ritonavir combinational therapy for the treatment of COVID-19 and the lessons learned from SARS-COV-2 variants. Expert Opinion on Drug Discovery. 18(12). 1301–1311. 2 indexed citations

Spera, Anna Maria. (2022). Hepatitis B virus infection reactivation in patients under immunosuppressive therapies: Pathogenesis, screening, prevention and treatment. World Journal of Virology. 11(5). 275–282. 8 indexed citations

Spera, Anna Maria. (2022). Safety of direct acting antiviral treatment for hepatitis C in oncologic setting: A clinical experience and a literature review. World Journal of Hepatology. 14(3). 525–534. 1 indexed citations

Spera, Anna Maria. (2021). Are nucleotide inhibitors, already used for treating hepatitis C virus infection, a potential option for the treatment of COVID-19 compared with standard of care? A literature review. World Journal of Virology. 10(2). 53–61.

Pagliano, Pasquale, Giuliana Scarpati, Carmine Sellitto, et al.. (2021). Experimental Pharmacotherapy for COVID-19: The Latest Advances. Journal of Experimental Pharmacology. Volume 13. 1–13. 25 indexed citations

Pagliano, Pasquale, Anna Maria Spera, Tiziana Ascione, & Silvano Esposito. (2020). Infections causing stroke or stroke-like syndromes. Infection. 48(3). 323–332. 17 indexed citations

Pagliano, Pasquale, Silvano Esposito, Tiziana Ascione, & Anna Maria Spera. (2020). Burden of Fungal Meningitis. Future Microbiology. 15(7). 469–472. 7 indexed citations

10.

Spera, Anna Maria, et al.. (2019). Alexithymia in HIV, HCV and coinfections.. PubMed. 27(1). 46–52. 1 indexed citations

11.

Spera, Anna Maria, Silvano Esposito, & Pasquale Pagliano. (2019). Emerging antibiotic resistance: carbapenemase-producing enterobacteria. Bad new bugs, still no new drugs.. PubMed. 27(4). 357–364. 14 indexed citations

12.

Spera, Anna Maria, et al.. (2019). Risk of professional accidental exposure to biological agents in health care workers: a retrospective analysis carried out in a southern Italian tertiary hospital.. PubMed. 27(1). 40–45. 11 indexed citations

13.

Tosone, Grazia, et al.. (2018). Epidemiology and pathogenesis of fulminant viral hepatitis in pregnant women. Minerva Obstetrics and Gynecology. 70(4). 480–486. 6 indexed citations

14.

Bianco, Vincenzo, et al.. (2017). An update on epidemiology of congenital rubella syndrome: how far from the World Health Organization goals?. Minerva Medica. 108(5). 483–485. 1 indexed citations

15.

Spera, Anna Maria, et al.. (2016). Antiviral therapy for hepatitis C: Has anything changed for pregnant/lactating women?. World Journal of Hepatology. 8(12). 557–557. 52 indexed citations

16.

Gentile, Ivan, Emanuela Zappulo, Antonio Riccardo Buonomo, et al.. (2014). Efficacy and Safety of Sofosbuvir in the Treatment of Chronic Hepatitis C: The Dawn of a New Era. Reviews on Recent Clinical Trials. 9(1). 1–7. 27 indexed citations

17.

Raimondi, Francesco, Anna Maria Spera, Maria Sellitto, Francesca Landolfo, & Letizia Capasso. (2012). Amino Acid–based Formula as a Rescue Strategy in Feeding Very‐Low‐Birth‐Weight Infants With Intrauterine Growth Restriction. Journal of Pediatric Gastroenterology and Nutrition. 54(5). 608–612. 10 indexed citations

18.

Arnold, Lesley M., et al.. (2011). A three-year, open-label, flexible-dosing study of milnacipran for the treatment of fibromyalgia. Journal of Pain. 12(4). P22–P22. 2 indexed citations

19.

Manzoni, Paolo, William Tarnow‐Mordi, Caterina Franco, et al.. (2010). Clinical use of lactoferrin in preterm neonates: an update.. PubMed. 62(3 Suppl 1). 101–4. 4 indexed citations

20.

Ferini‐Strambi, Luigi, Anna Maria Spera, A. Oldani, et al.. (1997). Autonomic function in narcolepsy: power spectrum analysis of heart rate variability. Journal of Neurology. 244(4). 252–255. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact